Cargando…
Cardiovascular health technology assessment: recommendations to improve the quality of evidence
The aim of this article is to review the role of Health Technology Assessment (HTA) organisations in appraising and recommending innovative cardiovascular technologies. We consider how bias impairs the quality of evidence from clinical trials involving cardiovascular healthcare technologies. Finally...
Autores principales: | Berry, Colin, Corcoran, David, Mangion, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443128/ https://www.ncbi.nlm.nih.gov/pubmed/30997126 http://dx.doi.org/10.1136/openhrt-2018-000930 |
Ejemplares similares
-
A cardiovascular disease policy model: part 2—preparing for economic evaluation and to assess health inequalities
por: Lawson, K D, et al.
Publicado: (2016) -
MRI-guided pulmonary vein isolation for atrial fibrillation: what is good enough? An early health technology assessment
por: Wenker, Steven, et al.
Publicado: (2019) -
Genesis of improved quality in imaging through a national Australian echocardiography registry
por: Eccleston, David, et al.
Publicado: (2022) -
Accrual monitoring in cardiovascular trials
por: Baldi, Ileana, et al.
Publicado: (2017) -
Cardiovascular imaging research priorities
por: MacArthur, Jacqueline Ann Langdon, et al.
Publicado: (2023)